Autolus Therapeutics announces pivotal Phase 2 FELIX clinical trial has met primary endpoint at interim analysis
In collaboration with Autolus’ academic partner, UCL, obe-cel is currently being evaluated in a Phase 1 clinical trial for B-NHL.
- In collaboration with Autolus’ academic partner, UCL, obe-cel is currently being evaluated in a Phase 1 clinical trial for B-NHL.
- Autolus has progressed obe-cel to the FELIX trial, a pivotal trial for r/r adult ALL.
- Autolus’ Phase 1b/2 clinical trial of obe-cel is enrolling adult patients with r/r B-precursor ALL.
- The trial had a Phase 1b component prior to proceeding to the single arm, Phase 2 clinical trial.